Commentary

Digital Ulcer Disease in Systemic Sclerosis

Publish date: May 18, 2012

 

Dr. Denton reported that he has financial relationships with
Actelion Pharmaceuticals, Aspreva, Biovitrum, Digna,
Encysive Pharmaceuticals, Genzyme, and Pfizer.

Pages

Recommended Reading

HIV Infection Complicates Rheumatologic Treatments and Vice Versa
MDedge Dermatology
Panel Recommends Tofacitinib Approval for Refractory RA
MDedge Dermatology
Biologics for RA Do Not Increase Solid Cancer Risk
MDedge Dermatology
Joint Involvement Less Common in Presence of Sjögren's Autoantibodies
MDedge Dermatology
Avoid Certain Vaccine-Biologic Combos
MDedge Dermatology
Smokers Less Likely to Respond to Biologic Treatment for RA
MDedge Dermatology
Could a Urine Test Predict Response to Biologics?
MDedge Dermatology
ACR Releases Updated Lupus Nephritis Guidelines
MDedge Dermatology
ACR Gives Special Consideration to Pregnancy in Nephritis Guidelines
MDedge Dermatology
Scleroderma Malignancy Risk Linked to Antinuclear Antibodies
MDedge Dermatology